Congratulations Mikhail Ermakov!
Mikhail Ermakov
Austrian Marshall Plan Fellow and interdisciplinary cancer scientist Mikhail Ermakov spent six months working and learning at the Laboratory of Systems Pharmacology at Harvard Medical School, where he and his colleagues were involved in the hands-on, pathology-focused application of spatial proteomics— recognized as the 2024 Method of the Year.
Support was provided by the European Association for Cancer Research (EACR), the Austrian Marshall Plan Foundation, and Ermakov’s PhD program at the Medizinische Universität Graz, including his supervisors,Karl Kashofer and Sigrid Regauer.
Congratulations Mikhail Ermakov!